Table 2.

The dfficulty of achieving the STRIDE-II proposed treatment goals and others in daily practice in patients with IBD (1 = minimum difficulty to 10 = maximum difficulty)^a.

Treatment goal	Difficulty
Clinical remission	4.27 (2.16)
Avoidance of surgery	4.55 (2.01)
Normalization of serum and fecal inflammatory biomarkers	4.82 (1.86)
Absence of disability	4.93 (1.92)
Normalization of quality of life	5.40 (1.76)
Mucosal healing	5.95 (1.72)
Absence of fatigue	6.00 (2.34)
Histologic remission	7.22 (1.64)
Transmural remission	7.24 (1.82)

Abbreviation: IBD, inflammatory bowel disease.

^aResults are expressed as mean (standard deviation).